Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) saw a large decline in short interest in the month of January. As of January 30th, there was short interest totaling 49,980 shares, a decline of 53.4% from the January 15th total of 107,279 shares. Approximately 6.8% of the shares of the company are sold short. Based on an average trading volume of 7,302,732 shares, the days-to-cover ratio is currently 0.0 days. Based on an average trading volume of 7,302,732 shares, the days-to-cover ratio is currently 0.0 days. Approximately 6.8% of the shares of the company are sold short.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Aditxt in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.
Check Out Our Latest Stock Analysis on ADTX
Aditxt Stock Down 0.3%
Aditxt Company Profile
Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.
The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.
Read More
- Five stocks we like better than Aditxt
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.
